MedReleaf acquires MED Colombia Cannabis cultivation and extracts production licence in Colombia will service a global supply chain MARKHAM, ON, July 24, 2018 /CNW/ – MedReleaf Corp. (TSX:LEAF) (“MedReleaf”...
Aphria plans for global cannabis leadership with international expansion acquiring leading assets in Latin America and the Caribbean Aphria medical brands to gain exposure to over 300 million people,...
Scythian Biosciences Corp Announces Colcanna SAS as one of the Industry’s First to Receive Key Cannabis Licences for the Cultivation, Extraction, Production and Research of Medical Cannabis for the...
TORONTO, July 5, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), a Canadian integrated medical cannabis company with its core operations in Colombia, announced...
Canopy Growth introduces Latin American subsidiary Canopy LATAM and announces the acquisition of leading Colombian medical cannabis company Announcement pairs Canopy Growth’s industry leading experience with regional expertise and...
President-Elect’s platform promises significant economic measures to increase foreign investment and international trade TORONTO, June 21, 2018 /CNW/ – Khiron life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN),...
Former DEA Chief of Pharmaceutical Investigations leading Khiron’s best-in-class procedures to self-regulate on diversion control TORONTO, June 19, 2018 /CNW/ – Khiron Life Sciences Corp. (TSXV: KHRN), a Canadian integrated medical...
Khiron Forms Exclusive Strategic Alliance with ILANS, Expanding Distribution Network to Over 500,000 Patients Demonstrates scalability and recurring revenue potential in the Colombian and Latin American markets TORONTO, June...
Khiron Achieves Key Milestone in Mission to Become First Medical Cannabis Company to Bring Products to Market in Colombia Colombian Agricultural Institute (“ICA”) authorization is a significant requirement to...
The Colombian Association of Internal Medicine and the Colombian Association of Neurology agree to support Khiron’s development of medical cannabis education, research and professional programs for nearly 3,000 doctors...
Under Mr. Murphy’s guidance, Khiron becomes only medical cannabis producer in Colombiawith DEA-level security protocols TORONTO, May 31, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV:KHRN), a Canadian...
Khiron Receives INVIMA Approval to Commercialize CBD Products for Colombian Domestic Sale and Export First Fully Licensed Company in Colombia to Receive INVIMA Approval TORONTO, May 30, 2018 /CNW/ – Khiron life Sciences...
TORONTO, May 29, 2018 /CNW/ – Khiron life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), a Canadian integrated medical cannabis company with its core operations in Colombia, announced today the Company is...
Khiron to Commence Trading on TSX Venture Exchange — First Canadian Cannabis Company with Core Operations in Colombia to List on Any Exchange Globally — — Khiron to Host...
Foreign Direct Investment In Cannabis Projects In Colombia. Is The Investment Safe There? Guest post by José Alejandro Abusaid, Founding Partner at Abusaid Gómez 1. Relevance of the...
PharmaCielo and AAJ Announce Private Placement of Subscription Receipts of PharmaCielo for Proceeds of up to $60 Million All financial figures in Canadian Dollars ($) unless otherwise noted TORONTO, April...
PharmaCielo Ltd. to Acquire Colombia’s Leading Provider of Telemedicine Services TORONTO, April 20, 2018 – PharmaCielo Ltd. (the “Company”) announces that it has reached an agreement to acquire Colombia’s...
ICC Labs Receives Two Additional Medicinal Cannabis Licenses in Colombia Highlights: The Ministry of Justice and Law of the Republic of Colombia granted ICC Labs a license for the...
Adent and Khiron Announce Closing of Subscription Receipt Financing TORONTO, Jan. 16, 2018 (GLOBE NEWSWIRE) — Further to the press releases dated November 7, 2017, and December 27, 2017,...
Australia-based Creso Pharma (ASX: CPH) (OTC: CRCPF) announced an expansion into Colombia, signing a deal to acquire licensed medical cannabis company Kunna Canada and its wholly owned subsidiary, Kunna...
Adent and Khiron Announce $6M Subscription Receipt Financing in Connection With the Business Combination TORONTO, Nov. 7, 2017 /CNW/ – Adent Capital Corp. (“Adent”) (NEX: ANT.H) and Khiron Life...
Exclusive Interview with Khiron Life Sciences CEO Alvaro Torres Colombia is a developing cannabis market that has captured the attention of many. A country known historically for being a...
Two privately-held cannabis companies based in Canada, Khiron Life Sciences and PharmaCielo, are now fully licensed by Colombia to produce low and high THC medical cannabis. Khiron disclosed the news...
FCM Global First Company to be Awarded Full Medical Cannabis Licensing in Colombia Cultivation, Processing, Manufacturing, and Export of Low-THC Cannabis Extracts for Medical and Research Uses MEDELLIN, Colombia...
Khiron First Company to Receive Licence for Cultivation of Medical Cannabis in Colombia TORONTO, Sept. 26, 2017 (GLOBE NEWSWIRE) — Khiron Life Sciences Corp. (“Khiron” or the “Company”) reports...
